PDSB · PDS Biotechnology Corporation
AI read · Good for PDSB
The AI's read
Lower spending can help conserve cash, but some savings came from clinical-trial costs. PDS Biotechnology reported $15.2 million in cash, and its PDS0301 trials remain ongoing with no new results reported.